- Home
- BRID vs ANVS Comparison
BRID vs ANVS Comparison
Compare BRID & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRID
- ANVS
- Stock Information
- Founded
- BRID 1932
- ANVS 2008
- Country
- BRID United States
- ANVS United States
- Employees
- BRID N/A
- ANVS N/A
- Industry
- BRID Specialty Foods
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- BRID Consumer Staples
- ANVS Health Care
- Exchange
- BRID Nasdaq
- ANVS Nasdaq
- Market Cap
- BRID 87.3M
- ANVS 92.6M
- IPO Year
- BRID N/A
- ANVS 2020
- Fundamental
- Price
- BRID $10.41
- ANVS $5.01
- Analyst Decision
- BRID
- ANVS Strong Buy
- Analyst Count
- BRID 0
- ANVS 6
- Target Price
- BRID N/A
- ANVS $29.67
- AVG Volume (30 Days)
- BRID 2.3K
- ANVS 488.6K
- Earning Date
- BRID 03-07-2025
- ANVS 11-08-2024
- Dividend Yield
- BRID N/A
- ANVS N/A
- EPS Growth
- BRID N/A
- ANVS N/A
- EPS
- BRID N/A
- ANVS N/A
- Revenue
- BRID $231,734,000.00
- ANVS N/A
- Revenue This Year
- BRID N/A
- ANVS N/A
- Revenue Next Year
- BRID N/A
- ANVS N/A
- P/E Ratio
- BRID N/A
- ANVS N/A
- Revenue Growth
- BRID N/A
- ANVS N/A
- 52 Week Low
- BRID $7.77
- ANVS $4.21
- 52 Week High
- BRID $14.69
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- BRID 51.47
- ANVS 44.02
- Support Level
- BRID $10.20
- ANVS $4.61
- Resistance Level
- BRID $10.50
- ANVS $4.95
- Average True Range (ATR)
- BRID 0.18
- ANVS 0.38
- MACD
- BRID -0.09
- ANVS 0.07
- Stochastic Oscillator
- BRID 42.47
- ANVS 40.40
About BRID Bridgford Foods Corporation
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are processing and distribution of frozen products, and processing and distribution of snack food products. It includes products such as biscuits, bread dough items, roll dough items, dry sausage products, and beef jerky. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. It derives a majority of its revenue from snack food products.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.